000250 — Sam Chun Dang Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Annual cashflow statement for Sam Chun Dang Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7,495	-10,361	8,832	-4,188	-5,078
Depreciation
Amortisation
Non-Cash Items	1,027	1,294	8,991	20,105	14,717
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-11,958	-5,380	-12,194	-920	3,103
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	3,250	-7,707	13,279	23,428	21,771
Capital Expenditures	-11,798	-29,307	-46,546	-21,973	-41,301
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7,409	-744	-7,392	13,552	18,143
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-19,206	-30,050	-53,938	-8,421	-23,158
Financing Cash Flow Items	-1,013	0	—	-0.099	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	14,662	27,691	13,325	3,387	65,759
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1,337	-9,822	-27,013	18,326	65,157